Strategy. Christian Mumenthaler, Group Chief Executive Officer

Similar documents
Swiss Re s differentiation approach drives performance

Underwriting. Matthias Weber, Group Chief Underwriting Officer

Capital Management. David Cole, Group Chief Financial Officer

Reinsurance. Moses Ojeisekhoba, CEO Reinsurance Alison Martin, Head L&H Business Management Reinsurance

Swiss Re s performance and strategy

Swiss Re s differentiation drives financial performance

Swiss Re and our Life & Health Reinsurance business

Swiss Re s performance and strategy. Bernstein s 13 th Strategic Decisions Conference John R. Dacey, Group Chief Strategy Officer, 22 September 2016

Annual EVM Results 2015 Investor and analyst presentation Zurich, 16 March We make the world more resilient.

Corporate Solutions. Agostino Galvagni, CEO Corporate Solutions Serge Troeber, CUO Corporate Solutions

Swiss Re s performance and strategy

Life Capital. Thierry Léger, CEO Life Capital Ian Patrick, CFO Life Capital

Capital allocation at the core of our strategy David Cole Group Chief Financial Officer

Risk Management. Patrick Raaflaub, Group Chief Risk Officer

Corporate Solutions. Agostino Galvagni CEO Corporate Solutions

Annual EVM Results 2016 Investor and analyst presentation Zurich, 16 March We make the world more resilient.

Financial strength and capital generation John Dacey, Group Chief Financial Officer

Goldman Sachs 18 th Annual European Financials Conference. Edouard Schmid, Head Property & Specialty Reinsurance Madrid, 10 June 2014

Swiss Re's performance. Gerhard Lohmann, CFO Reinsurance KBW European Financials Conference, 16 September 2015

Helvea Swiss Equities Conference. Guido Fuerer, Group Chief Investment Officer 16 January 2014

Underwriting priorities. Edi Schmid, Group Chief Underwriting Officer

SECOND QUARTER 2015 results

Update on Group strategy. Christian Mumenthaler, Group Chief Executive Officer

Swiss Re s performance and strategy. HSBC European Financials West Coast Symposium 6 April 2016

Annual EVM Results Zurich, 18 March 2015

Group strategy update. Michel M. Liès, Group Chief Executive Officer Investors' Day, Zurich, 24 June 2013

An integrated economic valuation and Key features accounting framework for business planning, pricing, reserving, and steering

News release. Swiss Re reports first quarter 2018 net income of USD 457 million; public share buy-back programme to start on 7 May 2018

Exane BNP Paribas 16th European CEO Seminar. Michel M. Liès, Group CEO Paris, 20 June 2014

Group strategic framework. Michel M. Liès Group Chief Executive Officer

Annual results Investor and analyst presentation Zurich, 23 February 2018

Underwriting performance and strong investment results support Swiss Re half-year 2017 net income of USD 1.2 billion

Swiss Re posts another strong quarterly profit of USD 802 million, contributing to a half-year net income of USD 2.0 billion

Swiss Re reports solid first quarter 2017 net income of USD 656 million

News release. Swiss Re reports first-quarter consolidated Group net income of USD 1.1 billion, on track to deliver on financial targets

Sustained insurance sector growth in 2017 largely based on demand from emerging markets

UBS Swiss Equity Conference

Creating the future. Investors and Media meeting Monte Carlo, 9 September 2013

News release. Page 1/6

Insurance industry needs to respond proactively to changing market dynamics in order to benefit from promising opportunities

Agenda Registration and welcome lunch. Michel M. Liès, Group CEO John R. Dacey, Group Chief Strategy Officer

Swiss Re investors and media meeting

Swiss Re proposes an 8.2% increase in the regular dividend to CHF 4.60 and a CHF 1.0 billion share buy-back programme

Into the eye of the future. Investors and Media meeting Monte Carlo, 10 September 2012

Investors Day 2009 Cycle management & portfolio steering

Swiss Re earns profit of USD 4.4 billion for 2013; regular dividend of CHF 3.85 per share and special dividend of CHF 4.15 per share to be proposed

News release. Page 1/8. Swiss withholding tax exempt distribution out of reserves from capital contributions. Contact:

2009 Annual Report Shareholders letter

Annual Results 2018 Swiss Re investor and analyst presentation Zurich, 21 February 2019

2011 Annual Report Letter to shareholders

Economic Value Management 2010 Report

First quarter 2014 results. Analyst and investor presentation Zurich, 7 May 2014

Draft 18 Draft 21. Annual results Analyst and investor presentation Zurich, 19 February 2015

Vontobel Summer Conference

Swiss Equities Conference

Cheuvreux Spring European Large Cap Conference

Future ready. Media conference, Monte Carlo, 14 September 2015

Merrill Lynch Banking & Insurance CEO Conference 2006

Credit Suisse Swiss Financials Conference

News release. Page 1/5. Contact: Media Relations, Zurich Telephone Corporate Communications, London

Creating value through reinsurance

2008 Annual Report Shareholders letter

Analysts conference call 13 February 2007

Analysts conference call 8 May 2007

Swiss Re. Susan Holliday Head of Investor Relations

Reserving 2008 Development of claim ratios by line of business

Dresdner Kleinwort s Speed Investing Conference

Analysts conference call 14 February 2006

Welcome Susan Holliday Introduction Capital management Financial Services Questions & answers

2006 Annual Turnover SCOR + Revios Pro Forma: EUR Million at current exchange rates

Swiss Re investors and media meeting

UBS Global Insurance Conference

2015 Annual Report Letter to Shareholders. We make the world more resilient. SRE004E

Second quarter 2013 results. Analyst and investor presentation Zurich, 8 August 2013

Market realities and renewals messages

Delivering on our Commitments Today and Tomorrow. Investor Presentation

UBS Conference Dr Arnoldussen, Swiss Re 7-8 July 2005, Frankfurt a. M. Non-life reinsurance in Germany

UBS Swiss Equity Conference

Strategic positioning in a competitive market

Economic Value Management 2014 Annual Report

Property & Casualty: Accelerating Profitable Growth

Third quarter 2013 results. Analyst and investor presentation Zurich, 7 November 2013

Talanx Strategy Frankfurt, 23 October Torsten Leue, CEO

Analysts conference call 3 April Life & Health Embedded Value 2006

Second Quarter 2012 results. Analyst and investor conference call Zurich, 09 August 2012

Economic Value Management 2016 Annual Report. For a resilient future

Conference call Swiss Re expects CHF 1.2 billion mark-to-market loss from its credit underwriting activities

Conference Call on Interim Report 3/2017

Building on our STRENGTHS. Investing in our FUTURE.

The right business mix for 2006

Investors Day. Zurich, 4 April 2018

Property & Casualty: AXA Asia P&C A story of acceleration and value creation

Zurich Financial Services Group Competing in the Age of Austerity

Gord Menzie SVP Corporate Finance & Treasury

Swiss Re Media Conference. Monte Carlo, 10 September 2018

Investors Day Update on market exposures Agenda. Strategic introduction David Blumer, Head of Financial Markets

Development of claim ratios by line of business

2007 Annual Report Shareholders letter

Third Quarter 2012 results. Analyst and investor presentation Zurich, 08 November 2012

BofA Merrill Lynch Conference 30 September, Mark Wilson Group CEO

Transcription:

Strategy Christian Mumenthaler, Group Chief Executive Officer

In the currently challenging environment we see attractive longterm opportunities Key challenges Long-term opportunities Soft market in the P&C world demand/supply imbalance industry consolidation Interest rates: low for longer Political instability and regulatory fragmentation Growing risk pools (GDP growth and demographic trends) High Growth Markets Closing the protection gap through better and lower cost offerings Ensuring access to risk pools is a top priority for Swiss Re 4

With our strategic framework, Swiss Re is well placed to face the industry challenges and seize opportunities I systematically allocate capital to risk pools / revenue streams II broaden and diversify client base to increase access to risk IV Swiss Re s strategic framework III emphasise differentiation optimise resources and platforms to support capital allocation Growth through systematic capital allocation Risk Knowledge supporting capital allocation Near-term priorities Large & tailored transactions Corporate Solutions Life Capital High Growth Markets Research & Development Technology People & Culture We are a risk knowledge company that invests in risk pools 5

Knowledge We invest in R&D to further strengthen our competitive advantage R&D activities amount to nearly 400 FTEs in 2016 Estimated allocation of R&D focused FTE across Swiss Re SONAR Trend spotting Principal Investments Centre for Global Dialogue Behavioural Research Casualty Risk Modelling Digital Analytics Catalyst Financial Risk Management Economic Research & Consulting (incl. sigma) Digital & Smart Analytics Centre Nat Cat Risk Modelling (incl. Cat Net) Group Structured R/I Solutions Reinsurance Centre Reinsurance Client Management/Business Services P&C Business Mgmt Casualty Products (incl. Cyber, Telematics) Property & Specialty Products (incl. product innovation in Agriculture, Aviation, etc.) P&C Reinsurance L&H BM L&H Products (incl. Magnum, Life Guide Health Platform, product innovation in Life or Critical Illness) L&H Reinsurance Casualty Risk Eng. Services Primary Lead P&C and Special Lines Property Risk Eng. Services Customer Engmt iptiq Platform elips Life Platform Closed Book Platform Corporate Life Solutions Capital How R&D drives competitive advantage: Unique selling proposition to clients: be a knowledge partner help clients underwrite (e.g. Life Guide, Cat Net) develop products together (Agriculture, Life, Critical Illness) Improve our processes: better risk selection (P&C and L&H underwriting) lowering risks (e.g. contract wording scanners) Build unique brand with regulators, governments etc. 6

Knowledge We have created a strong asset base of risk knowledge Selected R&D investments over past 25 years (man-years) 0 100 200 300 400 L&H Products (L&H Reinsurance) Nat Cat Risk Modelling (Group) Property & Specialty Products (P&C Reinsurance) Economic Research & Consulting (Group) Property Risk Eng. Services (Corporate Solutions) Casualty Products (P&C Reinsurance) Casualty Risk Eng. Services (Corporate Solutions) Casualty Risk Modelling (Group) Structured R/I Solutions (P&C Reinsurance) Building knowledge and competence through R&D has been our focus for a long time We have built up an enormous amount of value Significant competitive advantage virtually impossible to replicate within a reasonable time frame Digital & Smart Analytics Centre (Group) We have invested over 3 200 man-years in R&D activities over the past 25 years Note: Estimates based on the cost of accumulated FTEs for the specific areas over the years of existence 7

Knowledge We are creating the Swiss Re Institute to further strengthen the differentiation component of our strategy Goals of the Swiss Re Institute: 1. Leverage and steer R&D activities across the organisation 2. Provide access point for our clients and other partners 3. Deploy more of the knowledge to concrete client opportunities 8

Knowledge Technological innovation gives us the opportunity to further differentiate and support our clients Selected initiatives on Group level (across the value chain) Cooperation and investments Cooperation through accelerator programmes Strategic investments Partnership with IBM Watson to build cognitive capabilities Internal digital competence centres Digital & Smart Analytics Digital Catalysts Behavioural Research Swiss Re has executed over 500 digital product or capability use-cases over the last three years elipslife 1 Digital health iptiq platform1 platform Agriculture Liability Risk Drivers (LRDTM ) Property risk screening Primary Lead pricing platform Digital Portal 1 Smoker propensity ALPHA Claims Manager Product Design Distribution & Sales Underwriting Business Management Claims Novel parametric insurance Automated L&H process platform Magnum Automotive Solutions Analytics & Scoring Platform Life & Health Underwriting Document Analytics Contracts intelligence Watson P&C Business Management Intelligence 1 Across the value chain Note: Non-exhaustive overview of selected digital innovation at Swiss Re 9

R&D will support our systematic allocation of capital to risk pools Swiss Re applies a holistic capital allocation approach Strategic ambition Capital allocation Business planning Performance assessment to systematically deploy capital to risk pools Property Casualty Specialty Mortality Longevity Health Liability risk pools Target Liability Portfolio (TLP) ILLUSTRATIVE 40+ liability portfolios and key asset classes considered Based on historic performance and future outlook Optimise financial metrics (EVM, US GAAP, cash flow) and risk appetite Asset risk pools Strategic Asset Allocation (SAA) Cash and short terms Government bonds Credit investments Equities Private equity Real estate ILLUSTRATIVE 10

Growth Swiss Re has been an agile capital allocator we are now executing the next phase of our strategy Historic Outlook 2012-2014 2015-2016 Short-term Long-term P&C Re Conventional Transactions L&H Re Corporate Solutions Life Capital Long-term, we are optimistic about the growth prospects of all our businesses Short-tem, we see opportunities in L&H Re, Life Capital and P&C transactions; we are more cautious about P&C conventional business Cash outflows to shareholders According to our Capital Management Priorities >USD 1bn 1 USD 0-1bn 1 <USD 0bn 1 1 Based on Group risk capital requirements (185% Group SST, S&P AA), except for shareholders flows which reflect cash outflows 11

This differentiation approach has enabled Swiss Re to generate higher margins and outperform Net operating margin (NOM) 1 2012 9M 2016 NOM Split by components Avg. 2012-9M 2016 20% 17% 13% 15% 10% 26% 19% 5% 0% 2012 2013 2014 2015 9M 2016-9% -6% Swiss Re 2 2 Reinsurers Swiss Re Reinsurers Operating expenses Gross income Swiss Re outperformed peers on average by 4%pts since 2012, driven by underwriting performance (risk selection, capital allocation and differentiation) 1 Net operating margin = Earnings before interest and tax / total revenues less participating business investment result 2 Average of Alleghany, Everest Re, Hannover Re, Munich Re, Partner Re, RGA and SCOR 12

Growth Large and tailored transactions in Reinsurance provide attractive growth in a challenging market Further cement differentiated economics model with clients through: direct C-suite interaction model delivering useful knowledge to clients common growth opportunities with clients writing large and tailored transactions P&C Re: further reduce capacity allocated to P&C conventional business if prices continue to fall L&H Re: continue to grow and act as balance to the P&C segment Return on Equity Reinsurance in % 20.5 19.2 16.2 14.8 High Growth Markets remain a key element of our growth strategy, even if temporarily challenged FY 13 FY 14 FY 15 9M 16 Reinsurance targets to deliver over-the-cycle ROEs of 10-15% in P&C and 10-12% in L&H 13

Growth Corporate Solutions will continue to grow in relevance with unchanged focus on profitability Short-term outlook is challenging with likely reduction of deployed capacity in the Excess Layer segments Long-term prospects remain positive Key initiative is investment in Primary Lead capabilities; rolled out in 14 core markets already Return on Equity Corporate Solutions in % Bolt-on acquisitions are an important element to support both Primary Lead and footprint broadening 9.6 12.5 15.5 8.6 Transformational M&A opportunities remain a long-term option FY 13 FY 14 FY 15 9M 16 Corporate Solutions targets to deliver 10-15% ROE over-the-cycle 14

Growth Life Capital increases access to attractive risk pools in open and closed L&H books A primary L&H powerhouse with insurance clients, pension funds and distribution partners Differentiating through leading edge underwriting and servicing capabilities Growing in the UK closed book market and monitoring opportunities in Continental Europe Return on Equity Life Capital in % 14.5 Entering new European markets with Group L&H (elipslife) 6.8 7.5 Accelerating growth in Individual L&H (iptiq) across Europe and launching in the US 0.6 FY 13 FY 14 FY 15 9M 16 Life Capital targets to deliver 6-8% ROE in the mid-term 15

Growth We have invested in High Growth Markets, establishing a strong presence and intend to maintain our leading position Asia Latin America Africa China #1 int. P&C reinsurer #2 int. L&H reinsurer #8 int. Commercial insurer ` India #2 int. P&C reinsurer #3 int. L&H reinsurer Indonesia #2 int. P&C reinsurer #3 int. L&H reinsurer Mexico #1 P&C reinsurer # 2 L&H reinsurer Brazil #3 int. P&C reinsurer #2 int. L&H reinsurer #3 int. Commercial insurer 1 Long-term focus Reinsurance Principal Investments (PI) Targeted by Reinsurance and Corporate Solutions Long-term focus Corporate Solutions 2012 9M 2016 2012 9M 2016 2012 9M 2016 FTEs 990 2 1 720 2 FTEs 280 740 FTEs 40 60 HGM premium % 9% 16% 3 HGM premium % 3% 4% 3 HGM premium % 3% 3% 3 1 Expected market position upon completion of the JV with Bradesco Seguros Large Risks 2 Including Shared Service Centre in India 3 Expected Premiums Earned FY2016 incl. Principal Investments (PI) 16

Growth We continue to invest in our differentiation and growth initiatives over the long-term 3% productivity savings p.a. (total of USD 0.4bn) 2012-2015 Invested in strategic priorities 2016+ Currently, the cost line contains above USD 250m of investments into the future per year 1. Primary Lead and other corporate insurance expansion 2. Organic and inorganic growth in Life Capital 3. High Growth Markets expansion 4. Technology investments including Finance Transformation Group functions Life Capital Corporate Solutions Reinsurance Life Capital closed book growth Large transactions Primary Lead & global footprint High Growth Markets Technology and R&D All of these investments have business plans with attractive IRRs We will continue with our save to invest philosophy to ensure long-term value creation for our shareholders We are continuing with our productivity savings to fund growth initiatives 17

Key takeaways Swiss Re is well positioned to face industry challenges and seize opportunities Our investments in R&D and technology are supporting differentiation and are valued by our clients We have been a successful capital allocator and will continue to enhance our capabilities As a knowledge company we will access the most attractive risk pools and target an optimal portfolio of assets and liabilities Growth Risk Knowledge Near-term priorities Large & tailored transactions Corporate Solutions Life Capital High Growth Markets Research & Development Technology People & Culture We aim to achieve our Group financial targets and continue to deliver sustainable shareholder value Group financial targets ROE risk free + 700bps over-the-cycle ENW per share growth 10% p.a. 18

Corporate calendar & contacts Corporate calendar 2017 23 February Annual Results 2016 Conference call 16 March Publication of Annual Report 2016 21 April 153 rd Annual General Meeting Zurich Investor Relations contacts Hotline E-mail +41 43 285 4444 Investor_Relations@swissre.com Philippe Brahin Jutta Bopp Manfred Gasser +41 43 285 7212 +41 43 285 5877 +41 43 285 5516 Chris Menth Iunia Rauch-Chisacof +41 43 285 3878 +41 43 285 7844

Cautionary note on forward-looking statements Certain statements and illustrations contained herein are forward-looking. These statements (including as to plans objectives, targets and trends) and illustrations provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical fact or current fact. Forward-looking statements typically are identified by words or phrases such as anticipate, assume, believe, continue, estimate, expect, foresee, intend, may increase and may fluctuate and similar expressions or by future or conditional verbs such as will, should, would and could. These forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Swiss Re s actual results of operations, financial condition, solvency ratios, capital or liquidity positions, or prospects to be materially different from any future results of operations, financial condition, solvency ratios, capital or liquidity positions, or prospects expressed or implied by such statements or cause Swiss Re to not achieve its published targets. Such factors include, among others: further instability affecting the global financial system and developments related thereto; further deterioration in global economic conditions; Swiss Re s ability to maintain sufficient liquidity and access to capital markets, including sufficient liquidity to cover potential recapture of reinsurance agreements, early calls of debt or debt-like arrangements and collateral calls due to actual or perceived deterioration of Swiss Re s financial strength or otherwise; the effect of market conditions, including the global equity and credit markets, and the level and volatility of equity prices, interest rates, credit spreads, currency values and other market indices, on Swiss Re s investment assets; changes in Swiss Re s investment result as a result of changes in its investment policy or the changed composition of its investment assets, and the impact of the timing of any such changes relative to changes in market conditions; uncertainties in valuing credit default swaps and other credit-related instruments; possible inability to realise amounts on sales of securities on Swiss Re s balance sheet equivalent to their mark-to-market values recorded for accounting purposes; the outcome of tax audits, the ability to realise tax loss carryforwards and the ability to realise deferred tax assets (including by reason of the mix of earnings in a jurisdiction or deemed change of control), which could negatively impact future earnings; the possibility that Swiss Re s hedging arrangements may not be effective; the lowering or loss of one of the financial strength or other ratings of one or more Swiss Re companies, and developments adversely affecting Swiss Re s ability to achieve improved ratings; the cyclicality of the reinsurance industry; uncertainties in estimating reserves; uncertainties in estimating future claims for purposes of financial reporting, particularly with respect to large natural catastrophes, as significant uncertainties may be involved in estimating losses from such events and preliminary estimates may be subject to change as new information becomes available; the frequency, severity and development of insured claim events; acts of terrorism and acts of war; mortality, morbidity and longevity experience; policy renewal and lapse rates; extraordinary events affecting Swiss Re s clients and other counterparties, such as bankruptcies, liquidations and other credit-related events; current, pending and future legislation and regulation affecting Swiss Re or its ceding companies, and the interpretation of legislation or regulations by regulators; legal actions or regulatory investigations or actions, including those in respect of industry requirements or business conduct rules of general applicability; changes in accounting standards; significant investments, acquisitions or dispositions, and any delays, unexpected costs or other issues experienced in connection with any such transactions; changing levels of competition; and operational factors, including the efficacy of risk management and other internal procedures in managing the foregoing risks. These factors are not exhaustive. Swiss Re operates in a continually changing environment and new risks emerge continually. Readers are cautioned not to place undue reliance on forward-looking statements. Swiss Re undertakes no obligation to publicly revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. This communication is not intended to be a recommendation to buy, sell or hold securities and does not constitute an offer for the sale of, or the solicitation of an offer to buy, securities in any jurisdiction, including the United States. Any such offer will only be made by means of a prospectus or offering memorandum, and in compliance with applicable securities laws.